Literature DB >> 3931147

Mianserin protein binding in serum and plasma from healthy subjects and patients with depression and rheumatoid arthritis.

C B Kristensen, L F Gram, P Kragh-Sørensen.   

Abstract

Mianserin protein binding was measured in serum from 43 healthy subjects and plasma from 12 elderly depressed patients and 23 patients with rheumatoid arthritis. Free fraction (mean +/- SD) was 5.5 +/- 0.7% in the healthy subjects, 5.0 +/- 0.8% in the elderly subjects and 6.0 +/- 1.0 in the patients with rheumatoid arthritis. In the group of elderly patients treated with mianserin, a high correlation (r = 0.83, P less than 0.001) between total and free concentrations of mianserin was found. In both groups a high linear correlation (r = +0.90, P less than 0.001) between the free fraction of mianserin and that of imipramine was found, the latter being about twice as high as for mianserin. In both healthy subjects and arthritis patients the degree of protein binding was positively correlated to the concentration of alpha 1-acid-glycoprotein and complement C3c, and somewhat more weakly to haptoglobin. In the healthy subjects protein binding was also highly positively correlated to the concentration of apolipoprotein B, whereas no such correlation was found in the rheumatoid arthritis patients. In the rheumatoid arthritis patients protein binding was highly correlated to the concentration of hemopexin and somewhat more weakly to ceruloplasmin and fibrinogen; a weak negative correlation to the concentration of albumin was also found. Since significant intercorrelations between the concentrations of these proteins were found, the correlation to the degree of binding of mianserin may not necessarily represent binding of the drug to the protein.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3931147     DOI: 10.1007/bf00431808

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  14 in total

1.  Plasma protein binding of basic drugs. II. Importance of alpha 1-acid glycoprotein for interindividual variation.

Authors:  K M Piafsky; O Borgå
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

2.  Variation of the concentrations of some plasma proteins in normal adults, in pregnant women and in newborns.

Authors:  P O Ganrot
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

3.  Serum protein changes during the acute phase reaction.

Authors:  M Werner
Journal:  Clin Chim Acta       Date:  1969-08       Impact factor: 3.786

4.  Binding of tricyclic antidepressants and perazine to human plasma. Methodology and findings in normals.

Authors:  M Brinkschulte; U Breyer-Pfaff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-07       Impact factor: 3.000

5.  Modifications of serum glycoproteins the days following a prolonged physical exercise and the influence of physical training.

Authors:  H Liesen; B Dufaux; W Hollmann
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1977-12-22

6.  Plasma protein binding of imipramine in patients with rheumatoid arthritis.

Authors:  C B Kristensen
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Protein binding of doxepin and desmethyldoxepin.

Authors:  R Virtanen; E Iisalo; K Irjala
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1982-08

8.  Binding and displacement of basic, acidic and neutral drugs in normal and orosomucoid-deficient plasma.

Authors:  E Pike; B Skuterud; P Kierulf; D Fremstad; S M Abdel Sayed; P K Lunde
Journal:  Clin Pharmacokinet       Date:  1981 Sep-Oct       Impact factor: 6.447

9.  Drug binding in sera deficient in lipoproteins, albumin or orosomucoid.

Authors:  E Pike; P Kierulf; B Skuterud; J E Bredesen; P K Lunde
Journal:  Br J Clin Pharmacol       Date:  1983-09       Impact factor: 4.335

10.  The contribution of alpha 1-acid glycoprotein, lipoproteins, and albumin to the plasma binding of perazine, amitriptyline, and nortriptyline in healthy man.

Authors:  M Brinkschulte; U Breyer-Pfaff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-10       Impact factor: 3.000

View more
  1 in total

1.  Variability in the elimination of mianserin in elderly patients.

Authors:  E J Begg; J R Sharman; J E Kidd; R Sainsbury; D W Clark
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.